Growth Metrics

Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders (2016 - 2025)

Zimmer Biomet Holdings has reported Net Income towards Common Stockholders over the past 17 years, most recently at $137.9 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at $137.9 million for Q4 2025, down 28.33% from a year ago — trailing twelve months through Dec 2025 was $705.0 million (down 17.78% YoY), and the annual figure for FY2025 was $705.1 million, changed.
  • Net Income towards Common Stockholders for Q4 2025 was $137.9 million at Zimmer Biomet Holdings, down from $231.2 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for ZBH hit a ceiling of $419.7 million in Q4 2023 and a floor of -$58.8 million in Q1 2022.
  • Median Net Income towards Common Stockholders over the past 5 years was $172.8 million (2024), compared with a mean of $146.2 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: tumbled 1351.06% in 2022 and later skyrocketed 495.75% in 2023.
  • Zimmer Biomet Holdings' Net Income towards Common Stockholders stood at -$29.2 million in 2021, then tumbled by 101.37% to -$58.8 million in 2022, then soared by 813.78% to $419.7 million in 2023, then plummeted by 54.16% to $192.4 million in 2024, then decreased by 28.33% to $137.9 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were $137.9 million (Q4 2025), $231.2 million (Q3 2025), and $153.4 million (Q2 2025) per Business Quant data.